Proactiveinvestors Interviews Bob Proulx on FDA Fast Track Status for MagSense® Imaging

Proactiveinvestors interviews Bob Proulx on what FDA's designation of MagSense® imaging as a "breakthrough device" means for the company and its investors:…


Imagion Biosystems Reports Progress on Regulatory Pathway

MELBOURNE, Australia, April 4, 2018 /PRNewswire/ -- Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier…


Audio Recording of December 2017 Investor Update Call — Listen Here

The audio file of the December 2017 Investor Update call is now available. Listen here:…